表紙
市場調査レポート

細菌性膣炎:世界の治験レビュー

Bacterial Vaginosis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 244195
出版日 ページ情報 英文 77 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
細菌性膣炎:世界の治験レビュー Bacterial Vaginosis Global Clinical Trials Review, H2, 2014
出版日: 2014年11月17日 ページ情報: 英文 77 Pages
概要

当レポートでは、世界の細菌性膣炎治療薬の臨床試験について調査し、地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、 中断(一時中止、廃止、打ち切り)された試験のリストなどを提供してお届けします。

イントロダクション

  • 細菌性膣炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 上位5ヶ国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 上位5ヶ国における治験件数; 中東/アフリカ地域
    • 主要国における治験件数; 中南米

G7諸国における治験件数

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数

フェーズ(相)別治験件数: E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

治験主要参加企業 - 細菌性膣炎 治療薬

有望な薬剤

  • 最新治験ニュース

治験のプロファイル

  • 代表的な企業の治験の概要
    • Starpharma Holdings Limited
    • Symbiomix Therapeutics, LLC
    • Merck & Co., Inc.
    • Ferring International Center S.A.
    • AmVac AG
    • Osel Inc.
    • Mission Pharmacal Company
    • Actavis plc
    • Arun Pharmaceuticals Limited
    • Alfa Wassermann S.p.A
  • 代表的な研究機関/病院の治験の概要
    • University of Alabama at Birmingham
    • University of Pittsburgh
    • Shiraz University of Medical Sciences
    • Lawson Health Research Institute
    • Centers for Disease Control and Prevention
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • Mount Sinai Hospital
    • The National Institute of Allergy and Infectious Diseases
    • Ahvaz Jundishapur University of Medical Sciences

5大治験プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2422CTIDB

GlobalData's clinical trial report, "Bacterial Vaginosis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Vaginosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Vaginosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial Vaginosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Bacterial Vaginosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Bacterial Vaginosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Bacterial Vaginosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Bacterial Vaginosis
    • Sep 09, 2014: Symbiomix Therapeutics Makes First Corporate Announcement: Completion of Enrollment in a Phase 2 Clinical Trial of SYM-1219 for Bacterial Vaginosis
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Starpharma Holdings Limited
      • Clinical Trial Overview of Starpharma Holdings Limited
      • Symbiomix Therapeutics, LLC
      • Clinical Trial Overview of Symbiomix Therapeutics, LLC
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Ferring International Center S.A.
      • Clinical Trial Overview of Ferring International Center S.A.
      • AmVac AG
      • Clinical Trial Overview of AmVac AG
      • Osel Inc.
      • Clinical Trial Overview of Osel Inc.
      • Mission Pharmacal Company
      • Clinical Trial Overview of Mission Pharmacal Company
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • Arun Pharmaceuticals Limited
      • Clinical Trial Overview of Arun Pharmaceuticals Limited
      • Alfa Wassermann S.p.A
      • Clinical Trial Overview of Alfa Wassermann S.p.A
    • Clinical Trial Overview of Top Institutes / Government
      • University of Alabama at Birmingham
      • Clinical Trial Overview of University of Alabama at Birmingham
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Shiraz University of Medical Sciences
      • Clinical Trial Overview of Shiraz University of Medical Sciences
      • Lawson Health Research Institute
      • Clinical Trial Overview of Lawson Health Research Institute
      • Centers for Disease Control and Prevention
      • Clinical Trial Overview of Centers for Disease Control and Prevention
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Mount Sinai Hospital
      • Clinical Trial Overview of Mount Sinai Hospital
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Ahvaz Jundishapur University of Medical Sciences
      • Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Starpharma Holdings Limited, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Symbiomix Therapeutics, LLC, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AmVac AG, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Osel Inc., 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mission Pharmacal Company, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arun Pharmaceuticals Limited, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfa Wassermann S.p.A, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai Hospital, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014*

List of Figures

List of Figures

  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top